Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?
British Journal of Dermatology2018Vol. 179(2), pp. 413–419
Citations Over TimeTop 10% of 2018 papers
Abstract
Systemic complement activation occurs in HS and may be used as a surrogate biomarker of HS. C5a stimulates overproduction of TNF-α and may be a future therapeutic target.
Related Papers
- → Complement mediators in ischemia–reperfusion injury(2006)126 cited
- → Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor(2018)19 cited
- → Complement Factor I Variants in Complement-Mediated Renal Diseases(2022)15 cited
- → Toxoplasma Infection Induces Sustained Up-Regulation of Complement Factor B and C5a Receptor in the Mouse Brain via Microglial Activation: Implication for the Alternative Complement Pathway Activation and Anaphylatoxin Signaling in Cerebral Toxoplasmosis(2021)14 cited
- → ODP141 Complement Activation and Homeostasis Works Primarily Through the Alternative Pathway in Polycystic Ovary Syndrome(2022)